TaqMan 5'-nuclease human immunodeficiency virus type 1 PCR assay with phage-packaged competitive internal control for high-throughput blood donor screening.
about
Use of Bacteriophage MS2 as an Internal Control in Viral Reverse Transcription-PCR AssaysFalse-Negative Results of PCR Assay with Plasma of Patients with Severe Viral Hemorrhagic FeverStrategic Approach To Produce Low-Cost, Efficient, and Stable Competitive Internal Controls for Detection of RNA Viruses by Use of Reverse Transcription-PCREvaluation and validation of total RNA extraction methods for microRNA expression analyses in formalin-fixed, paraffin-embedded tissuesDirect DNA amplification from crude clinical samples using a PCR enhancer cocktail and novel mutants of TaqValidation of laboratory-developed molecular assays for infectious diseasesArmored RNA as virus surrogate in a real-time reverse transcriptase PCR assay proficiency panelComparative evaluation of the performance of the Abbott RealTime HIV-1 assay for measurement of HIV-1 plasma viral load on genetically diverse samples from GreeceNucleic acid amplification technology methods used in blood donor screening.Detection, differentiation, and quantitation of pathogenic leishmania organisms by a fluorescence resonance energy transfer-based real-time PCR assay.Development of an internal positive control for rapid diagnosis of avian influenza virus infections by real-time reverse transcription-PCR with lyophilized reagents.One-Step Reverse-Transcription FRET-PCR for Differential Detection of Five Ebolavirus Species.The Molecular Characterization of Intestinal Explant HIV Infection Using Polymerase Chain Reaction-Based Techniques.Stable and noncompetitive RNA internal control for routine clinical diagnostic reverse transcription-PCRSL1 revisited: functional analysis of the structure and conformation of HIV-1 genome RNA.Optimization of PCR for quantification of simian immunodeficiency virus genomic RNA in plasma of rhesus macaques (Macaca mulatta) using armored RNAFirst transmission of human immunodeficiency virus Type 1 by a cellular blood product after mandatory nucleic acid screening in Germany.Yield of HCV and HIV-1 NAT after screening of 3.6 million blood donations in central Europe.Preparation of His-tagged armored RNA phage particles as a control for real-time reverse transcription-PCR detection of severe acute respiratory syndrome coronavirus.Novel application of Locked Nucleic Acid chemistry for a Taqman assay for measuring diverse human immunodeficiency virus type 1 subtypes.Acute infections, cost and time to reporting of HIV test results in three U.S. State Public Health Laboratories.Epidemiological trends of HIV-1 infection in blood donors from Catalonia, Spain (2005-2014).Internal control for real-time polymerase chain reaction based on MS2 bacteriophage for RNA viruses diagnostics.First results of detection of PRRSV and CSFV RNA by SYBR Green I-based quantitative PCR.Preparation of armored RNA as a control for multiplex real-time reverse transcription-PCR detection of influenza virus and severe acute respiratory syndrome coronavirus.Quantification of human immunodeficiency virus type 1 proviral DNA by the TaqMan real-time PCR assay.Evaluation of an automated high-volume extraction method for viral nucleic acids in comparison to a manual procedure with preceding enrichment.Construction of armored RNA containing long-size chimeric RNA by increasing the number and affinity of the pac site in exogenous rna and sequence coding coat protein of the MS2 bacteriophage.Derivatives of Bst-like Gss-polymerase with improved processivity and inhibitor tolerance.NAT screening of blood donors for severe acute respiratory syndrome coronavirus can potentially prevent transfusion associated transmissions.Balance module allows consistent monitoring and documentation of the pooling process for nucleic acid amplification technology testing.Nucleic acid test screening of blood donors for orthopoxviruses can potentially prevent dispersion of viral agents in case of bioterrorism.Using a bioaerosol personal sampler in combination with real-time PCR analysis for rapid detection of airborne viruses
P2860
Q27472032-04446E4E-AF03-4C2B-8F5F-FA549A72039FQ27473053-4054E2AC-7363-49CA-9151-DC31DC25D78FQ27484878-C5236E9A-60D2-4F85-B468-390276D4603CQ33327648-AC9EC94A-9A2D-4208-9674-8F6DD269E0B6Q33856203-DB139A85-55B0-42CF-8CF8-AF5AE51C55D5Q33983153-BECFCA76-3E8D-47A4-9C79-5132498A6E12Q34315438-9AA4BA91-600B-463C-A85D-7A14DCF65691Q34547246-8DBAEB44-FC74-47C8-8812-07482630C621Q34830170-395CE4E9-F980-4381-9F7F-7E45E32D1CBDQ34975222-747A03B7-A0DB-4089-9B4E-EAD497B1B2DDQ35073260-E9DE4653-8059-4014-A190-47D018A3081DQ35643774-CE828F8A-A2B6-44F7-B802-D536C233D97EQ36078433-02CCB534-B6D8-4DF0-9167-13B4F9060F24Q36599982-C9DFEE41-D1ED-4DEC-9893-8659ABEE8A5EQ37410486-5806F22B-D424-439A-9F18-C0DC1024003EQ37478847-877339CB-4873-476F-96E2-F426C857428FQ38421534-C7F31638-EBB2-45B9-9B03-AF9D8F586AF5Q38454850-B1372140-7A83-4359-AED4-3AB3C42AEA18Q38479169-6BD392DD-5450-49F9-A1E5-1F0FA9784BD1Q38871741-E0E75B43-572C-4FFC-85A6-DA58FF93219FQ39727750-95E5F86B-8F76-4C95-9B6F-064A4E1AA5F2Q40133561-F6A1A42B-4B3D-4CFE-828F-64F91226522EQ40245627-0AFD3040-9158-42CC-96EA-D5FE0B4B8A5FQ40463905-E3EEEC15-8FB1-4937-BC19-799CD7BB1728Q42061453-B93FADF8-3822-44E9-B906-1B1E76B020BAQ42789109-8D54C861-B491-4BE1-83AE-D96E185C43F2Q42994370-AC0ED8C1-B1A6-4B90-8641-43A3D4515A1CQ47227326-0DEEC9E5-18EC-4753-8663-DE3C25A53216Q47651113-4284395C-7B78-4DF6-8E9C-3F2DE3889EE8Q48001785-08C75069-B6BB-44AB-BC11-C1B6CE8BD152Q50692599-BFECD91E-CE14-4ECE-AF8A-AEAA38FFF8DDQ50773025-FDC2063B-A61E-459F-970D-95BD4CDC7236Q56795730-9340D182-9999-451A-878D-F252D03C3FFC
P2860
TaqMan 5'-nuclease human immunodeficiency virus type 1 PCR assay with phage-packaged competitive internal control for high-throughput blood donor screening.
description
2001 nî lūn-bûn
@nan
2001 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
TaqMan 5'-nuclease human immun ...... oughput blood donor screening.
@ast
TaqMan 5'-nuclease human immun ...... oughput blood donor screening.
@en
type
label
TaqMan 5'-nuclease human immun ...... oughput blood donor screening.
@ast
TaqMan 5'-nuclease human immun ...... oughput blood donor screening.
@en
prefLabel
TaqMan 5'-nuclease human immun ...... oughput blood donor screening.
@ast
TaqMan 5'-nuclease human immun ...... oughput blood donor screening.
@en
P2093
P2860
P1476
TaqMan 5'-nuclease human immun ...... oughput blood donor screening.
@en
P2093
P2860
P304
P356
10.1128/JCM.39.12.4302-4308.2001
P407
P577
2001-12-01T00:00:00Z